NCT05390190

Brief Summary

Onychomycosis is the most common nail disease, representing more than 50% of all onychopathies.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

May 20, 2022

Last Update Submit

May 24, 2022

Conditions

Onychomycosis

Outcome Measures

Primary Outcomes (1)

  • Onychomycosis severity index

    Clinical assessment

    3 months

Study Arms (1)

Non ablative radiofrequency

EXPERIMENTAL

Device

Device: Non ablative radiofrequency

Interventions

Non ablative radiofrequencyDEVICE

Device

Non ablative radiofrequency

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Onychomycosis patients

You may not qualify if:

  • Patients with excessive manual work

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Onychomycosis

Condition Hierarchy (Ancestors)

TineaDermatomycosesMycosesBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousNail DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

May 20, 2022

First Posted

May 25, 2022

Study Start

July 1, 2022

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

May 25, 2022

Record last verified: 2022-05